Summary: S.1049 — 115th Congress (2017-2018)All Information (Except Text)

There is one summary for S.1049. Bill summaries are authored by CRS.

Shown Here:
Introduced in Senate (05/04/2017)

Opioid Addiction Risk Transparency Act

This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.